XIV Daily Inverse VIX Short-Term ETN
- Inverse Volatility
XIV - Profile
- Issuer: VelocityShares
- Structure: ETN
- Expense Ratio: 1.35%
- ETF Home Page: XIV
- Inception: Nov 29, 2010
- Tax Form: 1099
- XIV Tracks This Index: S&P 500 VIX Short-Term Futures Index Excess Return (-100%)
- 52 Week Lo: $24.67
- 52 Week Hi: $47.66
- AUM: $460.4 M
- Shares: 11.3 M
Alternative ETFs in the Inverse Volatility Category
|Type||Ticker||Expense Ratio||Assets||Avg. Daily Vol||YTD Return|
|Most Liquid (Volume)|
|Top YTD Performer|
The index is designed to reflect the returns that are potentially available through an unleveraged investment in short-term futures contracts on the CBOE Volatility Index.
XIV - Realtime Rating
Realtime Rating Summary
XIV is a leveraged ETN that is linked to VelocityShares. The index is designed to reflect the returns that are potentially available through an unleveraged investment in short-term futures contracts on the CBOE Volatility Index.
The adjacent table gives investors an individual Realtime Rating for XIV on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Inverse Volatility with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
XIV In-Depth Analysis
The following tables and charts contain in-depth metrics for XIV and compare it to similar peer ETFs within its ETFdb Category.
XIV - Expenses & Fees
This section compares the cost efficiency of XIV to peers in the same ETFdb Category.
Expenses Ratio Analysis
Commission Free Trading in XIV
XIV is not currently available for commission free trading on any platforms.
Category Commission Free Trading
There are 0 other ETFs in the Inverse Volatility ETFdb Category that are also eligible for commission free trading:
XIV - Performance
This section shows how XIV has performed relative to its peer group ETFdb Category.
XIV - Charts
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of XIV relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
XIV - Technicals
XIV Volatility Analysis
This section shows how the volatility of XIV compares to the peer group ETFdb Category.
- 20 Day MA: $36.65
- 60 Day MA: $32.49
- MACD 15 Period: 2.04
- MACD 100 Period: 6.52
- Williams % Range 10 Day: 28.41
- Williams % Range 20 Day: 21.39
- RSI 10 Day: 64
- RSI 20 Day: 63
- RSI 30 Day: 60
- Ultimate Oscillator: 63
XIV Bollinger Bands
- Lower Bollinger (10 Day): $35.29
- Upper Bollinger (10 Day): $41.46
- Lower Bollinger (20 Day): $32.31
- Upper Bollinger (20 Day): $40.85
- Lower Bollinger (30 Day): $29.80
- Upper Bollinger (30 Day): $40.55
XIV Support & Resistance
- Support Level 1: $38.53
- Support Level 2: $37.68
- Resistance Level 1: $39.95
- Resistance Level 2: $40.52
- Stochastic Oscillator %D (1 Day): 68.81
- Stochastic Oscillator %D (5 Day): 67.84
- Stochastic Oscillator %K (1 Day): 65.88
- Stochastic Oscillator %K (5 Day): 75.73
Latest XIV News
Best & Worst Weekly Performers: October 18th Edition
Best & Worst Weekly Performers: August 18th Edition
ETF Pick of the Month: Profit from Volatility
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.